English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1983]
News [3217]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
Advances in multiple myeloma from EHA 2012
Prof Meletios Dimopoulos - Univeristy of Athens, Greece
Advances in multiple myeloma from EHA 2012 ( Prof Meletios Dimopoulos - Univeristy of Athens, Greece )
4 Jul 2012
Advances in multiple myeloma from EHA 2012; bortezomib and beyond
Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology...
Advances in multiple myeloma from EHA 2012; bortezomib and beyond ( Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology, Vienna, Austria )
4 Jul 2012
Dasatinib vs. imatinib first-line in CML; new study data
Prof Giuseppe Saglio - University of Turin, Italy
Dasatinib vs. imatinib first-line in CML; new study data ( Prof Giuseppe Saglio - University of Turin, Italy )
4 Jul 2012
The evolving landscape in CML management
Dr Delphine Rea - Saint Louis Hospital, Paris
The evolving landscape in CML management ( Dr Delphine Rea - Saint Louis Hospital, Paris )
4 Jul 2012
AZA in MDS, and managing the older MDS patient
Prof Valeria Santini – University of Florence, Italy
AZA in MDS, and managing the older MDS patient  ( Prof Valeria Santini – University of Florence, Italy )
4 Jul 2012
Lenalidomide in low-risk MDS del(5q)
Prof Aristoteles Giagounidis - St. John’s Hospital, Duisburg, Germany
Lenalidomide in low-risk MDS del(5q) ( Prof Aristoteles Giagounidis - St. John’s Hospital, Duisburg, Germany )
4 Jul 2012
EHA 2012 advances in lymphoma; lenalidamide and beyond
Prof John Gribben - Barts & The London Trust Cancer Centre, UK; Prof Gilles...
EHA 2012 advances in lymphoma; lenalidamide and beyond ( Prof John Gribben - Barts & The London Trust Cancer Centre, UK; Prof Gilles Salles - Universite Claude Bernard, Lyon, France )
29 Jun 2012
Identifying drug sensitivity and resistance in acute myeloid leukaemia
Dr Mark Frattini – Memorial Sloan-Kettering Cancer Center, New York, USA
Identifying drug sensitivity and resistance in acute myeloid leukaemia  ( Dr Mark Frattini – Memorial Sloan-Kettering Cancer Center, New York, USA )
27 Jun 2012
Addressing the problem of adherence to treatment
Giora Sharf – Israeli CML Patients Support Group
Addressing the problem of adherence to treatment ( Giora Sharf – Israeli CML Patients Support Group )
27 Jun 2012
Patient and doctor communication and quality of life guidelines
Jan Geissler – CML Advocates Network
Patient and doctor communication and quality of life guidelines ( Jan Geissler – CML Advocates Network  )
27 Jun 2012
GFI is crucial for AML1-ETO induced acute myeloid leukemia
Dr Bert van der Reijden – Radboud University Nijmegen Medical Centre, Holland
GFI is crucial for AML1-ETO induced acute myeloid leukemia ( Dr Bert van der Reijden – Radboud University Nijmegen Medical Centre, Holland )
26 Jun 2012
Signaling and targeting cellular pathways in leukaemia metabolism
Dr Jing Chen – Emory University School of Medicine, Atlanta, USA
Signaling and targeting cellular pathways in leukaemia metabolism ( Dr Jing Chen – Emory University School of Medicine, Atlanta, USA )
26 Jun 2012
<1...143144145146147...166>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top